2cm7: Difference between revisions
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Crystal structures of protein-tyrosine phosphatase 1B in complex with | Crystal structures of protein-tyrosine phosphatase 1B in complex with compounds bearing a novel isothiazolidinone (IZD) heterocyclic phosphonate mimetic reveal that the heterocycle is highly complementary to the catalytic pocket of the protein. The heterocycle participates in an extensive network of hydrogen bonds with the backbone of the phosphate-binding loop, Phe(182) of the flap, and the side chain of Arg(221). When substituted with a phenol, the small inhibitor induces the closed conformation of the protein and displaces all waters in the catalytic pocket. Saturated IZD-containing peptides are more potent inhibitors than unsaturated analogs because the IZD heterocycle and phenyl ring directly attached to it bind in a nearly orthogonal orientation with respect to each other, a conformation that is close to the energy minimum of the saturated IZD-phenyl moiety. These results explain why the heterocycle is a potent phosphonate mimetic and an ideal starting point for designing small nonpeptidic inhibitors. | ||
==Disease== | ==Disease== | ||
Line 17: | Line 17: | ||
[[Category: Protein-tyrosine-phosphatase]] | [[Category: Protein-tyrosine-phosphatase]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
[[Category: Ala, P | [[Category: Ala, P J.]] | ||
[[Category: Becker-Pasha, M.]] | [[Category: Becker-Pasha, M.]] | ||
[[Category: Bower, M.]] | [[Category: Bower, M.]] | ||
[[Category: Burn, T | [[Category: Burn, T C.]] | ||
[[Category: Combs, A | [[Category: Combs, A P.]] | ||
[[Category: Douty, B.]] | [[Category: Douty, B.]] | ||
[[Category: Gonneville, L.]] | [[Category: Gonneville, L.]] | ||
[[Category: Hillman, M | [[Category: Hillman, M C.]] | ||
[[Category: Hollis, G | [[Category: Hollis, G F.]] | ||
[[Category: Klabe, R.]] | [[Category: Klabe, R.]] | ||
[[Category: Polam, P.]] | [[Category: Polam, P.]] | ||
[[Category: Reid, B | [[Category: Reid, B G.]] | ||
[[Category: Wasserman, Z.]] | [[Category: Wasserman, Z.]] | ||
[[Category: Wayland, B.]] | [[Category: Wayland, B.]] | ||
[[Category: Wei, M.]] | [[Category: Wei, M.]] | ||
[[Category: Wynn, R.]] | [[Category: Wynn, R.]] | ||
[[Category: Yue, E | [[Category: Yue, E W.]] | ||
[[Category: IZD]] | [[Category: IZD]] | ||
[[Category: acetylation]] | [[Category: acetylation]] | ||
Line 44: | Line 44: | ||
[[Category: protein phosphatase]] | [[Category: protein phosphatase]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:50:07 2008'' |
Revision as of 17:50, 21 February 2008
|
STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS
OverviewOverview
Crystal structures of protein-tyrosine phosphatase 1B in complex with compounds bearing a novel isothiazolidinone (IZD) heterocyclic phosphonate mimetic reveal that the heterocycle is highly complementary to the catalytic pocket of the protein. The heterocycle participates in an extensive network of hydrogen bonds with the backbone of the phosphate-binding loop, Phe(182) of the flap, and the side chain of Arg(221). When substituted with a phenol, the small inhibitor induces the closed conformation of the protein and displaces all waters in the catalytic pocket. Saturated IZD-containing peptides are more potent inhibitors than unsaturated analogs because the IZD heterocycle and phenyl ring directly attached to it bind in a nearly orthogonal orientation with respect to each other, a conformation that is close to the energy minimum of the saturated IZD-phenyl moiety. These results explain why the heterocycle is a potent phosphonate mimetic and an ideal starting point for designing small nonpeptidic inhibitors.
DiseaseDisease
Known diseases associated with this structure: Abdominal body fat distribution, modifier of OMIM:[176885], Insulin resistance, susceptibility to OMIM:[176885]
About this StructureAbout this Structure
2CM7 is a Single protein structure of sequence from Homo sapiens with as ligand. Active as Protein-tyrosine-phosphatase, with EC number 3.1.3.48 Known structural/functional Site: . Full crystallographic information is available from OCA.
ReferenceReference
Structural basis for inhibition of protein-tyrosine phosphatase 1B by isothiazolidinone heterocyclic phosphonate mimetics., Ala PJ, Gonneville L, Hillman MC, Becker-Pasha M, Wei M, Reid BG, Klabe R, Yue EW, Wayland B, Douty B, Polam P, Wasserman Z, Bower M, Combs AP, Burn TC, Hollis GF, Wynn R, J Biol Chem. 2006 Oct 27;281(43):32784-95. Epub 2006 Aug 17. PMID:16916797
Page seeded by OCA on Thu Feb 21 16:50:07 2008
Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)
OCA- Pages with broken file links
- Homo sapiens
- Protein-tyrosine-phosphatase
- Single protein
- Ala, P J.
- Becker-Pasha, M.
- Bower, M.
- Burn, T C.
- Combs, A P.
- Douty, B.
- Gonneville, L.
- Hillman, M C.
- Hollis, G F.
- Klabe, R.
- Polam, P.
- Reid, B G.
- Wasserman, Z.
- Wayland, B.
- Wei, M.
- Wynn, R.
- Yue, E W.
- IZD
- Acetylation
- Endoplasmic reticulum
- Hydrolase
- Oxidation
- Phosphatase
- Phosphorylation
- Polymorphism
- Protein phosphatase